✦ LIBER ✦

IMPACT OF PRETREATMENT ISCHEMIA ON THERAPEUTIC RISK REDUCTION AND LONG-TERM PROGNOSIS IN PATIENTS WITH STABLE ANGINA: RESULTS FROM COURAGE TRIAL

✍ Scribed by Leslee J. Shaw; Daniel S. Berman; David J. Maron; Rory Hachamovitch; Pamela M. Hartigan; James K. Min; Steven P. Sedlis; Marcin Dada; G.B. John Mancini; Robert A. O'Rourke; John A. Spertus; Bernard R. Chaitman; Eric R. Bates; Koon K. Teo; William E. Boden; William S. Weintraub

Book ID: 118580505
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 107 KB
Volume: 55
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(10)60926-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of Optimal Medical Therapy With o

Impact of Optimal Medical Therapy With or Without Percutaneous Coronary Intervention on Long-Term Cardiovascular End Points in Patients With Stable Coronary Artery Disease (from the COURAGE Trial)

✍ William E. Boden; Robert A. O'Rourke; Koon K. Teo; David J. Maron; Pamela M. Har 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 258 KB

Impact of left ventricular function and

Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial

✍ Leslee J. Shaw PhD, Manuel D. Cerqueira MD, Maria M. Brooks PhD, Andrew D. Altho 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 723 KB

Impact of Diabetes on Long-Term Prognosi

Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non-Q-Wave Myocardial Infarction : Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry

✍ Malmberg, K.; Yusuf, S.; Gerstein, H. C.; Brown, J.; Zhao, F.; Hunt, D.; Piegas, 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 358 KB

Trial suggests long term trapidil reduce

Trial suggests long term trapidil reduces cardiovascular events and improves prognosis in coronary artery disease: Abstracted from: Hirayama A, Kodama K, Yui Y et al. Effect of trapidil on cardiovascular events in patients with coronary artery disease (Results from the Japan Multicenter Investigation for Cardiovascular Diseases-Mochida [JMIC-M]). Am J Cardiol 2003; 92: 789–93

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 135 KB